Shares of Moderna (NASDAQ: MRNA) climbed 5.5% on Thursday after the biotechnology company said that it had struck a deal with a key manufacturer for its experimental COVID-19 vaccine.
Moderna will collaborate with European pharmaceutical company Laboratorios Farmaceuticos ROVI to potentially produce large-scale quantities of Moderna's novel coronavirus vaccine candidate mRNA-1273.
Moderna stock rose on Thursday on news of a new international supply deal. Image source: Getty Images.
Source Fool.com